PCR-based technology is used to detect point mutations by mixing polynucleotides with a fluorescence tag with patient DNA and performing PCR to generate signals indicating mutations
Luxturna is a gene therapy administered to patients with vision loss due to mutations in the RPE65 gene, restoring vision by providing a working copy of the gene